O3‐04–07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
Year: 2008
Type: article
Study design: Clinical Trial
Source: Alzheimer s & Dementia
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keyword: methylene blue
Open Access status: closed
OpenAlex ID: W2137228730
